Technical / White Paper

Accelerating Early Drug Development – Reality or Wishful Thinking?

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Solvias AG - Chemical and analytical development, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Accelerating Early Drug Development – Reality or Wishful Thinking?

This article focuses on the main aspects to consider when deciding whether or not to outsource chemical and analytical development – including small-scale cGMP API production – to support an early drug development program.

Related resources from Solvias AG - Chemical and analytical development

Show more

Show more

Supplier info centre